Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Steroid-induced glaucoma is optic nerve damage linked with elevated eye pressure caused by corticosteroid use. The pressure rise happens when steroids reduce fluid outflow through the eye's drainage system. Many people feel no symptoms while pressure climbs, so damage can occur quietly. Early detection through pressure checks can prevent permanent vision loss.
read more about steroidinduced glaucoma ...Corticosteroids can raise intraocular pressure by changing the trabecular meshwork, which slows aqueous outflow. Risk rises with stronger steroids, higher dose, longer duration, and frequent use. Steroid drops, periocular injections, inhaled steroids, and systemic steroids can all trigger a pressure response in susceptible individuals. People with a personal or family history of glaucoma, high myopia, diabetes, or young age can have a stronger pressure rise. The pressure response can appear within weeks, though timing varies by steroid type and exposure.
Most cases have no early symptoms, which is why routine pressure checks matter during steroid use. When pressure becomes very high, eye pain, headache, halos around lights, and nausea can occur. Blurred vision can happen from corneal swelling during a large pressure spike. Peripheral vision loss is a later sign and can be missed without formal testing. Any severe eye pain or sudden vision loss while using steroids needs urgent evaluation.
Diagnosis starts with measuring intraocular pressure and reviewing current and recent steroid exposure. Optic nerve exam and retinal nerve fiber layer imaging can detect early damage, even when vision still feels normal. Visual field testing checks for subtle peripheral loss that develops with glaucoma. Gonioscopy can confirm that the drainage angle is open and can rule out other mechanisms for pressure rise. Repeated measurements help confirm that pressure improves after steroid changes, which supports the diagnosis.
Treatment usually includes reducing, stopping, or switching the steroid under clinician guidance, since abrupt stopping is not safe for every condition. Pressure-lowering drops are often used to bring pressure down while the steroid effect fades. When steroid therapy must continue, an eye doctor can choose the lowest-risk option and monitor pressure more often. Laser or surgical glaucoma treatment is considered when pressure stays high despite drops or when optic nerve damage progresses. Ongoing follow-up is important because future steroid exposure can trigger another pressure rise.
Pressure can rise within weeks of starting steroids, especially with potent topical drops. In some cases, the rise happens sooner, depending on dose and individual response. Longer courses raise risk further, particularly without monitoring. Regular pressure checks during steroid therapy help catch early changes.
Often, yes, pressure drops after steroid exposure ends, though timing varies. Some people return to baseline within days to weeks, while others need longer, especially after long-term use. If optic nerve damage has started, vision loss does not reverse, even if pressure improves. Follow-up confirms that pressure stabilizes safely.
Risk is higher in people with glaucoma, a family history of glaucoma, high myopia, diabetes, and in children. Potent steroids and long-term use also raise risk. The form of steroid matters, since frequent topical exposure near the eye can have a strong effect. An eye doctor can tailor monitoring based on risk.
Steroid-Induced Glaucoma. EyeWiki. https://eyewiki.org/Steroid-Induced_Glaucoma. Date Accessed February 4, 2026.
Steroid-Induced Glaucoma - StatPearls - NCBI Bookshelf. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK430903/. Date Accessed February 4, 2026.
Characteristics and Management of Steroid-Induced Glaucoma. American Academy of Ophthalmology (EyeNet). https://www.aao.org/eyenet/article/management-of-steroid-induced-glaucoma. Date Accessed February 4, 2026.
Steroid-Induced Glaucoma: An Avoidable Irreversible Blindness. PubMed Central (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC5577123/. Date Accessed February 4, 2026.
Corticosteroid-induced Glaucoma: A Review of the Literature. Nature (Eye). https://www.nature.com/articles/6701895. Date Accessed February 4, 2026.